KalVista Pharmaceuticals, Inc.
KALVDelisted Jun 11, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001348911
KalVista Pharmaceuticals, Inc. was delisted on Jun 11, 2026; its insiders filed their last Form 4 on Jun 11, 2026; 184 institutions reported holding it in 13F filings for Q1 2026, worth $1.39B in total; no superinvestor held it.
13F holders, Q1 2024
Institutional positions in KalVista Pharmaceuticals, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 129
- +36 vs. Q4 2023
- Shares held
- 47.0M
- +10.0M (+27.1%) vs. Q4 2023
- Total value
- $557.2M
- +$104.2M (+23.0%) vs. Q4 2023
- New holders
- 47
- 33 more added
- Sold out
- 11
- 35 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting KALV on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $189 |
| Q1 2026 | 184 | $1.39B |
| Q4 2025 | 162 | $1.08B |
| Q3 2025 | 145 | $714.0M |
| Q2 2025 | 140 | $615.5M |
| Q1 2025 | 128 | $633.7M |
| Q4 2024 | 130 | $467.4M |
| Q3 2024 | 122 | $561.0M |
| Q2 2024 | 119 | $568.2M |
| Q1 2024 | 129 | $557.2M |
| Q4 2023 | 93 | $453.0M |
| Q3 2023 | 101 | $349.2M |
| Q2 2023 | 94 | $310.1M |
| Q1 2023 | 88 | $265.0M |
| Q4 2022 | 91 | $236.2M |
| Q3 2022 | 94 | $372.0M |
| Q2 2022 | 91 | $238.7M |
| Q1 2022 | 89 | $363.9M |
| Q4 2021 | 97 | $314.6M |
| Q3 2021 | 105 | $408.2M |
| Q2 2021 | 110 | $582.7M |
| Q1 2021 | 117 | $605.1M |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding KalVista Pharmaceuticals, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Jane Street Group, LLC | 344,449 | $4.09M | 0.01% | +306,932+818.1% | Added |
| Candriam Luxembourg S.C.A. | 350,000 | $4.15M | 0.03% | +350,000 | New |
| Soleus Capital Management, L.P. | 386,000 | $4.58M | 0.40% | +386,000 | New |
| Morgan Stanley | 424,434 | $5.03M | 0.00% | −28,000−6.2% | Reduced |
| Perceptive Advisors LLC | 500,000 | $5.93M | 0.10% | +500,000 | New |
| Emerald Mutual Fund Advisers Trust | 529,365 | $6.28M | 0.33% | +529,365 | New |
| Driehaus Capital Management LLC | 541,538 | $6.42M | 0.06% | −487,030−47.4% | Reduced |
| Silverarc Capital Management, LLC | 561,183 | $6.66M | 1.87% | +449,449+402.2% | Added |
| Dimensional Fund Advisors LP | 579,659 | $6.87M | 0.00% | −137,305−19.2% | Reduced |
| State Street Corp | 594,173 | $7.05M | 0.00% | +57,071+10.6% | Added |
| Marshall Wace, LLP | 628,887 | $7.46M | 0.01% | +628,887 | New |
| Geode Capital Management, LLC | 651,888 | $7.73M | 0.00% | +21,840+3.5% | Added |
| Vestal Point Capital, LP | 655,000 | $7.77M | 0.64% | +655,000 | New |
| Emerald Advisers, LLC | 671,176 | $7.96M | 0.32% | +671,176 | New |
| MPM Oncology Impact Management LP | 760,722 | $9.02M | 1.45% | +760,722 | New |
| DAFNA Capital Management LLC | 806,973 | $9.57M | 2.18% | +205,941+34.3% | Added |
| StemPoint Capital LP | 1,161,060 | $13.8M | 3.68% | +737,886+174.4% | Added |
| TCG Crossover Management, LLC | 1,163,356 | $13.8M | 1.09% | −2,232,139−65.7% | Reduced |
| First Turn Management, LLC | 1,179,420 | $14.0M | 2.09% | +1,179,420 | New |
| Saturn V Capital Management LLC | 1,441,952 | $17.1M | 6.86% | −365,611−20.2% | Reduced |
| Capital World Investors | 1,464,606 | $17.4M | 0.00% | +1,464,606 | New |
| Boxer Capital, LLC | 1,590,000 | $18.9M | 0.93% | −60,000−3.6% | Reduced |
| Vanguard Group Inc | 1,685,113 | $20.0M | 0.00% | −96,306−5.4% | Reduced |
| BlackRock Inc. | 2,432,234 | $28.8M | 0.00% | +190,209+8.5% | Added |
| Adage Capital Partners GP, L.L.C. | 2,575,000 | $30.5M | 0.06% | +1,870,000+265.2% | Added |
| Frazier Life Sciences Management, L.P. | 3,687,867 | $43.7M | 1.85% | +65,573+1.8% | Added |
| Tang Capital Management LLC | 4,125,345 | $48.9M | 5.09% | +685,000+19.9% | Added |
| Suvretta Capital Management, LLC | 4,192,005 | $49.7M | 2.10% | +1,508,000+56.2% | Added |
| VR Adviser, LLC | 6,249,731 | $74.1M | 3.53% | +2,157,000+52.7% | Added |
| Vivo Capital, LLC | 0 | $0 | 0.00% | −856,008−100.0% | Sold out |
| Caption Management, LLC | 0 | $0 | 0.00% | −165,000−100.0% | Sold out |
| Opaleye Management Inc. | 0 | $0 | 0.00% | −150,000−100.0% | Sold out |
| Affinity Asset Advisors, LLC | 0 | $0 | 0.00% | −125,969−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −14,772−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −11,905−100.0% | Sold out |
| Bridgeway Capital Management, LLC | 0 | $0 | 0.00% | −10,500−100.0% | Sold out |
| AJOVista, LLC | 0 | $0 | 0.00% | −4,920−100.0% | Sold out |
| Belvedere Trading LLC | 0 | $0 | 0.00% | −4,170−100.0% | Sold out |
| Garner Asset Management Corp | 0 | $0 | 0.00% | −135−100.0% | Sold out |
| The PNC Financial Services Group, Inc. | 0 | $0 | 0.00% | −5−100.0% | Sold out |